BRAF and MEK inhibition beyond dabrafenib-trametinib in advanced thyroid cancer: a real-world case series
晚期甲状腺癌中,除达拉非尼-曲美替尼外,BRAF和MEK抑制剂的疗效:一项真实世界病例系列研究
期刊:Frontiers in Endocrinology
影响因子:4.6
doi:10.3389/fendo.2026.1694805
Yamin, Tzahi; Cohen, Oded; Robenshtok, Eyal; Izkhakov, Elena; Miodovnik, Mor; Gutfeld, Orit; Leshem, Yasmin; Meirovitz, Roman; Warshavsky, Anton; Muhanna, Nidal; Finkel, Inbar